Tango Therapeutics Inc

TNGXNASDAQ · US

Holders

REDUCEDT+7
Crystal Adam
Tango Therapeutics Inc · NASDAQ
−600 sh · $15.2K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Crystal Adam
Tango Therapeutics Inc · NASDAQ
+27,000 sh · $140.4K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Crystal Adam
Tango Therapeutics Inc · NASDAQ
−26,400 sh · $645.6K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+30
Newcomb Jessica
Tango Therapeutics Inc · NASDAQ
−5,100 sh · $122.2K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Newcomb Jessica
Tango Therapeutics Inc · NASDAQ
−700 sh · $16.0K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Newcomb Jessica
Tango Therapeutics Inc · NASDAQ
−2,400 sh · $60.4K
Filed 24 Sept 2026SEC Form 4view source
ACQUIREDStale
Crystal Adam
Tango Therapeutics Inc · NASDAQ
+27,000 sh · $140.4K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Crystal Adam
Tango Therapeutics Inc · NASDAQ
−27,000 sh · $603.9K
Filed 3 Sept 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Tango Therapeutics Inc · NASDAQ
173,132 sh · $3.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Tango Therapeutics Inc · NASDAQ
3,987,852 sh · $34.2M
Filed 30 Jun 2024SEC 13Fview source